A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT01965509

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01965509
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01965509. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
Intervention (Drug)
PEX168 or placebo
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd. (class: industry)
Collaborator
China-Japan Friendship Hospital (class: other)

Record details

Record id
cardio:ct-nct01965509
Content hash
cf937c5737028b610cef703c55aba03cf4838a5382cd3b8f8885c85e6888da50